350 mg Tablets: white, round, unscored tablets debossed “2410 V” on one side and plain on the reverse side; available in bottles of 15, 20, 21, 30, 42, 60, 90 and 120.
Store at 20°-25°C (68°-77°F) [see USP Controlled Room Temperature].
Patients should be advised to contact their physician if they experience any adverse reactions to carisoprodol tablets.
Since carisoprodol tablets may cause drowsiness and/or dizziness, patients should be advised to assess their individual response to carisoprodol tablets before engaging in potentially hazardous activities such as driving a motor vehicle or operating machinery [see Warnings and Precautions (5.1)].
Patients should be advised to avoid alcoholic beverages while taking carisoprodol tablets and to check with their doctor before taking other CNS depressants such as benzodiazepines, opioids, tricyclic antidepressants, sedating antihistamines, or other sedatives [see Warnings and Precautions (5.1)].
Patients should be advised that treatment with carisoprodol tablets should be limited to acute use (up to two or three weeks) for the relief of acute, musculoskeletal discomfort. If symptoms still persist, patients should contact their healthcare provider for further evaluation.
Huntsville, AL 35811
Rebel Distributors Corp.
Thousand Oaks, CA 91320
| CARISOPRODOL |
|Labeler — Rebel Distributors Corp. (118802834)|
|Rebel Distributors Corp.||118802834||repack, relabel|
Revised: 12/2009 Rebel Distributors Corp.
All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.